𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists

✍ Scribed by Shore, N D; Abrahamsson, P-A; Anderson, J; Crawford, E D; Lange, P

Book ID
121651419
Publisher
Nature Publishing Group
Year
2012
Tongue
English
Weight
862 KB
Volume
16
Category
Article
ISSN
1365-7852

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Can multiparametric magnetic resonance i
Can multiparametric magnetic resonance imaging predict upgrading of transrectal ultrasound biopsy results at more definitive histology?11Mohamed Abd-Alazeez receives funding from the Egyptian government. Mark Emberton and Hashim U. Ahmed receive funding from USHIFU and Advanced Medical Diagnostics for clinical trials. Mark Emberton is a paid consultant for Steba Biotech, USHIFU and Sanofi-Aventis. Mark Emberton has received research support by GSK for a study evaluating the role of MRI in men with prostate cancer. Mark Emberton and Hashim Ahmed have previously received medical consultancy fees from GE Healthcare/Oncura and Hashim Ahmed previously from Steba Biotech. Mark Emberton is a medical director of Mediwatch PLC. Hashim Uddin Ahmed and Mark Emberton receive funding from the Medical Research Council, the NIHR-HTA, NIHR-i4i, the US NIH/NCI, Pelican Cancer Foundation, Prostate Cancer UK, and St PeterΧ³s Trust. This work was part funded by research support for Mark Emberton and Alex Kirkham from the UK National Institute of Health Research UCLH/UCL Comprehensive Biomedical Research Centre, London, UK.
✍ Abd-Alazeez, Mohamed; Ahmed, Hashim U.; Arya, Manit; Allen, Clare; Dikaios, Niko πŸ“‚ Article πŸ“… 2014 πŸ› Elsevier Science 🌐 English βš– 415 KB